Form 4: Aquestive Therapeutics Executive's Stock Transaction

Aquestive Therapeutics SVP of Regulatory Affairs, Melina Cioffi, disposed of 2,083 shares of common stock to cover tax obligations related to RSU vesting.

Summary

• Melina Cioffi, SVP of Regulatory Affairs at Aquestive Therapeutics, Inc. (AQST), reported a transaction on December 2, 2025.
• The transaction involved the disposition of 2,083 shares of common stock.
• The shares were disposed of at a price of $5.93 per share.
• This disposition was to satisfy tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units (RSUs).
• Following this transaction, Melina Cioffi beneficially owns 200,178 shares of common stock directly.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary transaction related to tax withholding for vested Restricted Stock Units, which is a standard compensation event and does not indicate positive or negative sentiment regarding the company's performance or prospects.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This is a routine insider transaction related to executive compensation and tax obligations, which is common across all industries when Restricted Stock Units (RSUs) vest. It does not provide specific insights into broader industry trends or competitive landscape.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine, non-discretionary transaction for tax purposes related to executive compensation, not a discretionary sale based on market sentiment.

Key Dates

Keywords

Aquestive Therapeutics, AQST, Form 4, Insider Transaction, Melina Cioffi, Restricted Stock Units, RSU vesting, tax withholding, common stock